Francisco Tustumi

Dr. Francisco Tustumi

Universidade de São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Revista do Colégio Brasileiro de Cirurgiões
Verified
Journal Article
Open access
PDF file
AMAndre Luiz Gioia Morrell
Andre Luiz Gioia Morrell
AMAlexander Charles Morrell-Junior
Alexander Charles Morrell-Junior
AMAllan Gioia Morrell
Allan Gioia Morrell
JMJose Mauricio Freitas Mendes
Jose Mauricio Freitas Mendes
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
AMAlexander Morrell
Alexander Morrell
The term “robot” was concepted in the beginning of last century, coming originally from the Czech word “robota”, meaning “labor”. More recently, computer assistance and robotics based in the telepresence and virtual reality concept have been applied to surgical procedures. The application of robots in surgery dates approximately 35 years, experiencing significant growth in the last two decades fueled by the advent of advanced technologies. Despite its recent and brief status in surgery history, robotic technology has already proven its enhanced visualization, superior dexterity and precision during minimally invasive procedures. Currently, the worldwide diffused and predominant robot system used in surgery is Da Vinci by Intuitive Surgical, however robotic surgery evolution is far from over, with multiple potential competitors on the horizon pushing forward its paradigms. We aim to describe the history and evolution of robotic surgery in the last years as well as present its future perspectives.

1 January 2023 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
NANelson Adami Andreollo
Nelson Adami Andreollo
JAJosé Eduardo de Aguilar-Nascimento
José Eduardo de Aguilar-Nascimento
The field of medicine has always been at the forefront of technological innovation, constantly seeking new strategies to diagnose, treat, and prevent diseases. Guidelines for clinical practice to orientate medical teams regarding diagnosis, treatment, and prevention measures have increased over the years. The purpose is to gather the most medical knowledge to construct an orientation for practice. Evidence-based guidelines follow several main characteristics of a systematic review, including systematic and unbiased search, selection, and extraction of the source of evidence. In recent years, the rapid advancement of artificial intelligence has provided clinicians and patients with access to personalized, data-driven insights, support and new opportunities for healthcare professionals to improve patient outcomes, increase efficiency, and reduce costs. One of the most exciting developments in Artificial Intelligence has been the emergence of chatbots. A chatbot is a computer program used to simulate conversations with human users. Recently, OpenAI, a research organization focused on machine learning, developed ChatGPT, a large language model that generates human-like text. ChatGPT uses a type of AI known as a deep learning model. ChatGPT can quickly search and select pieces of evidence through numerous databases to provide answers to complex questions, reducing the time and effort required to research a particular topic manually. Consequently, language models can accelerate the creation of clinical practice guidelines. While there is no doubt that ChatGPT has the potential to revolutionize the way healthcare is delivered, it is essential to note that it should not be used as a substitute for human healthcare professionals. Instead, ChatGPT should be considered a tool that can be used to augment and support the work of healthcare professionals, helping them to provide better care to their patients.

19 July 2017 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
WBW. M. Bernardo
W. M. Bernardo
JRJ. R. M. da Rocha
J. R. M. da Rocha
SSS. Szachnowicz
S. Szachnowicz
FSF. C. Seguro
F. C. Seguro
ICI. Cecconello
I. Cecconello
Achalasia of the cardia is associated with an increased risk of esophageal carcinoma. The real burden of achalasia at the malignancy genesis is still a controversial issue. Therefore, there are no generally accepted recommendations on follow-up evaluation for achalasia patients. This study aims to estimate the risk of esophageal adenocarcinoma and squamous cell carcinoma in achalasia patients. We searched for association between carcinoma and esophageal achalasia in databases up to January 2017 to perform a systematic review and meta-analysis. A total of 1,046 studies were identified from search strategy, of which 40 were selected for meta-analysis. A cumulative number of 11,978 esophageal achalasia patients were evaluated. The incidence of squamous cell carcinoma was 312.4 (StDev 429.16) cases per 100,000 patient-years at risk. The incidence of adenocarcinoma was 21.23 (StDev 31.6) cases per 100,000 patient-years at risk. The prevalence for esophageal carcinoma was 28 carcinoma cases in 1,000 esophageal achalasia patients (CI 95% 2, 39). The prevalence for squamous cell carcinoma was 26 cases in 1,000 achalasia patients (CI 95% 18, 39) and for adenocarcinoma was 4 cases in 1,000 achalasia patients (CI 95% 3, 6).The absolute risk increase for squamous cell carcinoma was 308.1 and for adenocarcinoma was 18.03 cases per 100,000 patients per year. To the best of our knowledge, this is the first meta-analysis estimating the burden of achalasia as an esophageal cancer risk factor. The high increased risk rate for cancer in achalasia patients points to a strict endoscopic surveillance for these patients. Also, the increased risk for developing adenocarcinoma in achalasia patients suggests fundoplication after myotomy, to avoid esophageal reflux and Barret esophagus, a known risk factor for adenocarcinoma.

1 December 2018 in HPB
Verified
Journal Article
Closed access
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
LELucas Ernani
Lucas Ernani
FCFabricio F. Coelho
Fabricio F. Coelho
WBWanderley M. Bernardo
Wanderley M. Bernardo
SJSérgio S. Junior
Sérgio S. Junior
PHPaulo Herman
Paulo Herman

27 February 2020 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ANAntonio Afonso de Miranda Neto
Antonio Afonso de Miranda Neto
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
IRIgor Braga Ribeiro
Igor Braga Ribeiro
AKAhmad Khan
Ahmad Khan
SSShailendra Singh
Shailendra Singh
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura

1 September 2016 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
CKCintia Mayumi Sakurai Kimura
Cintia Mayumi Sakurai Kimura
FTFlavio Roberto Takeda
Flavio Roberto Takeda
RURodrigo Hideki Uema
Rodrigo Hideki Uema
RSRubens Antônio Aissar Salum
Rubens Antônio Aissar Salum
ICIvan Cecconello
Ivan Cecconello
Background: Despite recent advances in diagnosis and treatment, esophageal cancer still has high mortality. Prognostic factors associated with patient and with disease itself are multiple and poorly explored. Aim: Assess prognostic variables in esophageal cancer patients. Methods: Retrospective review of all patients with esophageal cancer in an oncology referral center. They were divided according to histological diagnosis (444 squamous cell carcinoma patients and 105 adenocarcinoma), and their demographic, pathological and clinical characteristics were analyzed and compared to clinical stage and overall survival. Results: No difference was noted between squamous cell carcinoma and esophageal adenocarcinoma overall survival curves. Squamous cell carcinoma presented 22.8% survival after five years against 20.2% for adenocarcinoma. When considering only patients treated with curative intent resection, after five years squamous cell carcinoma survival rate was 56.6 and adenocarcinoma, 58%. In patients with squamous cell carcinoma, poor differentiation histology and tumor size were associated with worse oncology stage, but this was not evidenced in adenocarcinoma. Conclusion: Weight loss (kg), BMI variation (kg/m²) and percentage of weight loss are factors that predict worse stage at diagnosis in the squamous cell carcinoma. In adenocarcinoma, these findings were not statistically significant.